<p>Data are means ± SEM.</p>*<p><i>P<</i>0.05 and</p>***<p><i>P<</i>0.001 DKO compared with C57BL/6 J mice;</p>$$<p><i>P</i><0.01 and</p>$$$<p><i>P</i><0.001 PPAR agonist-treated compared with placebo-treated DKO mice;</p>£<p><i>P</i><0.05 and</p>£££<p><i>P</i><0.001 rosiglitazone-treated compared with fenofibrate-treated DKO mice.</p
<p><b>a</b> Differentiated adipocytes were incubated with 50 µmol/L LA (L) or <i>t</i>10<i>c</i>12 C...
OBJECTIVE - We investigated whether the dual PPARα/γ agonist tesaglitazar has anti-atherogenic effec...
<p>Peroxisome proliferative-activated receptor (PPAR)α, PPARγ coactivator (PGC)-1α, phospho-The<sup>...
<p>(<b>A</b>) Representative Mac-3 staining of aortic sinus plaques of placebo-, fenofibrate- and ro...
<p>(<b>A</b>) Effect of six weeks PPAR agonists treatments on PPARγ and PPARα mRNA expression levels...
In this study, we determined the in vitro effect of peroxisome proliferator-activated receptor-γ (PP...
In this study, we determined the in vitro effect of peroxisome proliferator-activated receptor-γ (PP...
<p>Effect of six weeks PPAR agonists treatments on plasma FFA levels of CM-PGKO mice (<b>white bars<...
<p>Effect of Rosiglitazone (R), Pioglitazone (P) and Fenofibrate (F) treatment on cardiomyocyte mRNA...
Peroxisome proliferator-activated receptors (PPAR) play an important role in the regulation of lipid...
<p>(<i>A</i>) Real time PCR results for PPARγ and PGC1α after 12 weeks of sVEGF-R1 induction (dTg-ON...
(A) BW of male mice from the BL background before (age 7–9 months) and after 60 days (age 9–11 month...
Synthetic peroxisome proliferator-activated receptor (PPAR) agonists are used to treat dyslipidemia ...
Understanding the molecular regulatory mechanisms controlling for myocardial lipid metabolism is of ...
<p>Effect of PPAR agonists on Myocardial lipid content in CM-PGKO mice (<b>white bars</b>) and litte...
<p><b>a</b> Differentiated adipocytes were incubated with 50 µmol/L LA (L) or <i>t</i>10<i>c</i>12 C...
OBJECTIVE - We investigated whether the dual PPARα/γ agonist tesaglitazar has anti-atherogenic effec...
<p>Peroxisome proliferative-activated receptor (PPAR)α, PPARγ coactivator (PGC)-1α, phospho-The<sup>...
<p>(<b>A</b>) Representative Mac-3 staining of aortic sinus plaques of placebo-, fenofibrate- and ro...
<p>(<b>A</b>) Effect of six weeks PPAR agonists treatments on PPARγ and PPARα mRNA expression levels...
In this study, we determined the in vitro effect of peroxisome proliferator-activated receptor-γ (PP...
In this study, we determined the in vitro effect of peroxisome proliferator-activated receptor-γ (PP...
<p>Effect of six weeks PPAR agonists treatments on plasma FFA levels of CM-PGKO mice (<b>white bars<...
<p>Effect of Rosiglitazone (R), Pioglitazone (P) and Fenofibrate (F) treatment on cardiomyocyte mRNA...
Peroxisome proliferator-activated receptors (PPAR) play an important role in the regulation of lipid...
<p>(<i>A</i>) Real time PCR results for PPARγ and PGC1α after 12 weeks of sVEGF-R1 induction (dTg-ON...
(A) BW of male mice from the BL background before (age 7–9 months) and after 60 days (age 9–11 month...
Synthetic peroxisome proliferator-activated receptor (PPAR) agonists are used to treat dyslipidemia ...
Understanding the molecular regulatory mechanisms controlling for myocardial lipid metabolism is of ...
<p>Effect of PPAR agonists on Myocardial lipid content in CM-PGKO mice (<b>white bars</b>) and litte...
<p><b>a</b> Differentiated adipocytes were incubated with 50 µmol/L LA (L) or <i>t</i>10<i>c</i>12 C...
OBJECTIVE - We investigated whether the dual PPARα/γ agonist tesaglitazar has anti-atherogenic effec...
<p>Peroxisome proliferative-activated receptor (PPAR)α, PPARγ coactivator (PGC)-1α, phospho-The<sup>...